NCT03443999Recruiting
S-FLEX Netherlands Registry: Prospective Evaluation of the Supraflex Family Sirolimus-eluting Coronary Stent System
Prospective Evaluation of the Supraflex Family Sirolimus-eluting Coronary Stent System in a 'Real-World' Patient Population
Source: ClinicalTrials.gov · Last updated 23 Apr 2026
Brief summary (registry, in English)
The primary objective of this registry is to evaluate the safety and efficacy of the Supraflex Family sirolimus-eluting coronary stent system in a 'real-world' patient population requiring stent implantation.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 10000 (estimated)
- First submitted
- 16 Feb 2018
- Start date
- 27 Feb 2018
- Primary completion date
- 30 Jun 2027
- Lead sponsor
- Sahajanand Medical Technologies Limited
- Diseases
- Coronary artery disease
- NCT number
- NCT03443999
What you commit to
- Study type: Observational
- Planned participants: 10000
- From 27 Feb 2018 to the primary completion date, 30 Jun 2027
- 7 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Lab values
- Planned surgery within 6-month of PCI unless dual anti-platelet therapy is maintained throughout the peri-surgical period
Other
- Women with known pregnancy or who are lactating
- High probability of non-adherence to the follow-up requirements (due to social, psychological or medical reasons)
- Currently participating in another study that has not completed the primary endpoint or that clinically interferes with the current registry requirements
Who the study is looking for
- Age ≥ 18 years
- The patient, or legal representative, has been informed of the nature of the registry and has consented to participate and authorised the collection and release of his/her medical information by signing a Patient Informed Consent Form
- Treating physician has electively implanted at least one Supraflex Family stent as part of the patient's planned clinical care.
- The patient is willing and able to cooperate with study procedures and required follow up visits
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (7)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Tergooi Ziekenhuis Coordinator of this site? Confirm its status | Blaricum | Netherlands | Recruiting |
| Amphia Ziekenhuis Coordinator of this site? Confirm its status | Breda | Netherlands | Recruiting |
| Albert Schweitzer Ziekenhuis Coordinator of this site? Confirm its status | Dordrecht | Netherlands | Recruiting |
| Catharina Ziekenhuis Coordinator of this site? Confirm its status | Eindhoven | Netherlands | Recruiting |
| Medical Center Leeuwarden Coordinator of this site? Confirm its status | Leeuwarden | Netherlands | Recruiting |
| Maasstad Ziekenhuis Coordinator of this site? Confirm its status | Rotterdam | Netherlands | Recruiting |
| ZorgSaam Hospital Coordinator of this site? Confirm its status | Terneuzen | Netherlands | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.